- ARCHIMED completed the acquisition of Standard BioTools' Microfluidics business, to operate as Biomark Scientific.
- Divestment sharpens company focus and monetizes legacy Fluidigm asset.
- Transaction financial terms were not detailed in the Item 7.01 filing excerpt.
Signal #114454 · SEC 8-K
$LAB SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $LAB filing catalyst
Why did $LAB trigger an AI stock catalyst alert?
$LAB triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +2.0/10). Headline: Standard BioTools Completes Sale of Microfluidics Business to ARCHIMED. Key points: - ARCHIMED completed the acquisition of Standard BioTools' Microfluidics business, to operate as Biomark Scientific. - Divestment sharpens company focus and monetizes legacy Fluidigm asset. - Transaction financial terms were not detailed in the Item 7.01 filing excerpt.
How did $LAB stock react after the SEC filing?
After the SEC 8-K for $LAB, observed market reaction: T0 price $0.61. Past moves do not guarantee future results.
Where can I get real-time $LAB SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $LAB via Telegram and the VIP Web Terminal from €10/month.